openPR Logo
Press release

Global Alzheimer Drugs Market Size, Share, Demands, Trend, Growth Rate, Drug Class and Forecasts to 2027

02-28-2022 04:05 PM CET | Health & Medicine

Press release from: ReportsnReports

The Global Alzheimer Drugs Market was valued at USD 6537.0 Million in the year 2021.

Diabetes, obesity, heart diseases and high blood pressure (BP), in confluence with sedentary lifestyles, unhealthy dietary patterns and smoking, are some of the factors known to increase the chances of developing Alzheimer's disease. An increase in the prevalence of these ailments and lifestyle choices among the masses, coupled with the rising geriatric population, represents one of the key factors driving the market growth. Furthermore, the leading pharmaceutical companies are focusing on the development of drugs that prevent the disease and provide long-lasting improvements in cognitive functions.

Get a Free Sample Copy of Global Alzheimer Drugs Market Research Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=5360266

In addition, the market growth is further supported by the expansion of telehealth services and the growing traction of online pharmacies. Telehealth can be defined as the remote delivery of clinical as well as non-clinical services through tele- and digital communication technologies. These platforms have enabled disease diagnosis and drug delivery in remote regions. Apart from this, various Alzheimer's drugs are presently under late-stage clinical trials, including Aducanumab and Solanezumab. The development of these drugs is anticipated to propel the market growth in the coming years.

Moreover, increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer’s drugs which in turn is driving the global Alzheimer’s drugs market. Also, rising R&D activities by pharmaceutical companies and research institutes for Alzheimers’ effective therapy is expected to boost the global Alzheimer’s drugs market.

Scope of the Report:
• The report presents the analysis of Alzheimer Drugs market for the historical period of 2017-2021 and the forecast period of 2022-2027
• The report analyses the Alzheimer Drugs Market by value (USD Million)
• The report analyses the Alzheimer Drugs Market by Drug Class (Cholinergic, Memantine, Combined drug, others).
• The report analyses the Alzheimer Drugs Market by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
• The Global Alzheimer Drugs Market has been analysed By Region (North America, Europe, Asia Pacific and LAMEA).
• The Global Alzheimer Drugs Market has been analysed By Country (United States, Canada, Germany, United Kingdom, France, Italy, China, Japan, India and Australia)
• The attractiveness of the market has been presented by region, by Drug Class and By Distribution Channel.
• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development.
• The companies analysed in the report include AbbVie Inc., F. Hoffman-La Roche, Ltd., Novartis AG, Biogen, Pfizer Inc., Eli Lilli and Company, Takeda Pharmaceutical Company Limited, Novo Nordisk, Daiichi Sankyo Company Ltd., Eisai Co. Ltd, NervGen Pharma.

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=5360266

Key Target Audience:
• Alzheimer Drugs Manufacturers
• Consulting and Advisory Firms
• Government and Policy Makers
• Regulatory Authorities

Table of Contents:

1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary

2. Strategic Recommendations
3. Alzheimer Drugs Market: Product Outlook

4. Global Alzheimer Drugs Market: Sizing and Forecast
4.1 Global Alzheimer Drugs Market Size, By Value, Year 2017-2027
4.2 Impact of COVID-19 on Global Alzheimer Drugs Market

5. Global Alzheimer Drugs Market Segmentation – By Drug Class, By Distribution Channel
5.1 Competitive Scenario of Global Alzheimer Drugs Market: By Drug Class
5.1.1 Cholinergic – Market Size and Forecast (2017-2027)
5.1.2 Memantine – Market Size and Forecast (2017-2027)
5.1.3 Combined drug – Market Size and Forecast (2017-2027)
5.1.4 Others – Market Size and Forecast (2017-2027)
5.3 Competitive Scenario of Global Alzheimer Drugs Market: By Distribution Channel
5.3.1 Hospitals Pharmacy– Market Size and Forecast (2017-2027)
5.3.2 Retail Pharmacy - Market Size and Forecast (2017-2027)
5.3.3 Online Pharmacy – Market Size and Forecast (2017-2027)

6. Global Alzheimer Drugs Market: Regional Analysis
6.1 Competitive Scenario of Global Alzheimer Drugs Market : By Region

7. North America Alzheimer Drugs Market: An Analysis (2017-2027)
7.1 North America Alzheimer Drugs Market : Size and Forecast (2017-2027), By Value
7.2 North America Alzheimer Drugs Market – Prominent Companies
7.3 Market Segmentation By Drug Class (Cholinergic, Memantine, Combined drug and Others)
7.4 Market Segmentation By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)
7.5 North America Alzheimer Drugs Market: Country Analysis
7.6 Market Opportunity Chart of North America Alzheimer Drugs Market - By Country, By Value, 2026
7.7 Competitive Scenario of North America Alzheimer Drugs Market: By Country
7.8 United States Alzheimer Drugs Market: Size and Forecast (2017-2027), By Value
7.9 United States Alzheimer Drugs Market Segmentation - By Drug Class, By Distribution Channel (2017-2027)
7.10 Canada Alzheimer Drugs Market: Size and Forecast (2017-2027), By Value
7.11 Canada Alzheimer Drugs Market Segmentation - By Drug Class, By Distribution Channel (2017-2027)

Get a 20% Discount on this Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=5360266

8. Europe Alzheimer Drugs Market: An Analysis (2017-2027)
8.1 Europe Alzheimer Drugs Market : Size and Forecast (2017-2027), By Value
8.2 Europe Alzheimer Drugs Market – Prominent Companies
8.3 Market Segmentation By Drug Class (Cholinergic, Memantine, Combined drug and Others)
8.4 Market Segmentation By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)
8.5 Europe Alzheimer Drugs Market: Country Analysis
8.6 Market Opportunity Chart of Europe Alzheimer Drugs Market - By Country, By Value, 2026
8.7 Competitive Scenario of Europe Alzheimer Drugs Market: By Country
8.8 Germany Alzheimer Drugs Market: Size and Forecast (2017-2027), By Value
8.9 Germany Alzheimer Drugs Market Segmentation - By Drug Class, By Distribution Channel (2017-2027)
8.10 United Kingdom Alzheimer Drugs Market: Size and Forecast (2017-2027), By Value
8.11 United Kingdom Alzheimer Drugs Market Segmentation - By Drug Class, By Distribution Channel (2017-2027)
8.12 France Alzheimer Drugs Market: Size and Forecast (2017-2027), By Value
8.13 France Alzheimer Drugs Market Segmentation - By Drug Class, By Distribution Channel (2017-2027)
8.14 Italy Alzheimer Drugs Market: Size and Forecast (2017-2027), By Value
8.15 Italy Alzheimer Drugs Market Segmentation - By Drug Class, By Distribution Channel (2017-2027)

9. Asia Pacific Alzheimer Drugs Market: An Analysis (2017-2027)
9.1 Asia Pacific Alzheimer Drugs Market : Size and Forecast (2017-2027), By Value
9.2 Asia Pacific Alzheimer Drugs Market – Prominent Companies
9.3 Market Segmentation By Drug Class (Cholinergic, Memantine, Combined drug and Others)
9.4 Market Segmentation By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)
9.5 Asia Pacific Alzheimer Drugs Market: Country Analysis
9.6 Market Opportunity Chart Asia Pacific Alzheimer Drugs Market - By Country, By Value, 2026
9.7 Competitive Scenario of Asia Pacific Alzheimer Drugs Market: By Country
9.8 China Alzheimer Drugs Market: Size and Forecast (2017-2027), By Value
9.9 China Alzheimer Drugs Market Segmentation - By Drug Class, By Distribution Channel (2017-2027)
9.10 Japan Alzheimer Drugs Market: Size and Forecast (2017-2027), By Value
9.11 Japan Alzheimer Drugs Market Segmentation - By Drug Class, By Distribution Channel (2017-2027)
9.12 India Alzheimer Drugs Market: Size and Forecast (2017-2027), By Value
9.13 India Alzheimer Drugs Market Segmentation - By Drug Class, By Distribution Channel (2017-2027)
9.14 Australia Alzheimer Drugs Market: Size and Forecast (2017-2027), By Value
9.15 Australia Alzheimer Drugs Market Segmentation - By Drug Class, By Distribution Channel (2017-2027)

10. Global Alzheimer Drugs Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends

11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Alzheimer Drugs Market - By Drug Class, 2026
11.2 Market Attractiveness Chart of Global Alzheimer Drugs Market - By Distribution Channel, 2026
11.3 Market Attractiveness Chart of Global Alzheimer Drugs Market - By Region, 2026

12. Competitive Landscape
12.1 Product Pipeline of Leading Alzheimer Drugs Companies
12.2 Market Share Analysis

13. Company Analysis
13.1 AbbVie Inc.,
13.2 F. Hoffman-La Roche, Ltd.
13.3 Novartis AG
13.4 Biogen
13.5 Pfizer Inc.,
13.6 Eli Lilli and Company
13.7 Takeda Pharmaceutical Company Limited
13.8 Novo Nordisk
13.9 Daiichi Sankyo Company Ltd.
13.10 Eisai Co. Ltd
13.11 NervGen Pharma

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

+ 1 888 391 5441
sales@reportsandreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Alzheimer Drugs Market Size, Share, Demands, Trend, Growth Rate, Drug Class and Forecasts to 2027 here

News-ID: 2566371 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase